Fundamental - Factsheet
Help
DAVITA INC
DAVITA
Updated on 25 Feb 2021 (End of trading day)
Last (USD): 102.140 |
Change: -0.750 |
High: 103.868 |
Change (%): -0.73 |
Low: 101.230 |
Open |
103.170 |
Yesterday's Close |
102.89 |
Buy Price |
- |
Sell Price |
- |
Buy Volume (share) |
- |
Sell Volume (share) |
- |
Cumulative Volume (share) |
538,373 |
Cumulative Value |
|
Key Statistics
(USD) a
|
7.15992 |
(USD) e |
7.15992 |
(USD) b |
12.6469 |
a
|
14.266 |
f |
14.266 |
b |
8.0763 |
(USD) d
|
- |
Cash In Hand
(USD) g |
4.5867 |
Issued & Paid-up Shares
c |
109,400,000 |
(%)
d
|
- |
Price / Cash In Hand
g |
22.269 |
Treasury Shares h |
12,283,977 |
Market Cap (M) |
11,174.116 |
Enterprise Value (M) |
23,359.410 |
|
7 |
Exchange Code |
DVA |
Par Value (
$
)
|
n.a. |
52 Weeks Volatility (%) |
43.15 |
|
- |
Sector & Industry |
Health Services
-
Medical/Nursing Services |
Notes:
-
Based on latest Full Year results announcement, adjusted for the current number of shares.
-
Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
-
-
Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
-
Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
-
Based on Trailing EPS.
-
Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
-
Rounded to the nearest thousand. Updated on 30 Oct 2020.
Peer Comparison
Type |
Name |
Market |
Market Cap (M)a |
b
|
c
|
d
|
(%)d
|
Reference |
DAVITA INC |
NYSE |
11,174.116 |
14.266 |
14.266 |
8.0763 |
- |
Industry |
Medical/Nursing Services
|
NYSE |
5,874.028 |
70.755 |
72.797 |
3.4676 |
0.023 |
Local Peer |
FRESENIUS MEDICAL CARE AG & CO KGAA SPON ADR-EACH REP 0.5 NPV |
NYSE |
20,519.173 |
15.282 |
- |
- |
- |
Local Peer |
OAK STREET HEALTH INC |
NYSE |
13,328.363 |
- |
- |
28.9555 |
- |
Local Peer |
INVITAE CORP |
NYSE |
7,388.154 |
- |
- |
3.7511 |
- |
Local Peer |
CHEMED CORP |
NYSE |
7,125.510 |
- |
22.304 |
7.9067 |
- |
Local Peer |
MEDNAX INC |
NYSE |
2,052.594 |
- |
- |
2.7460 |
- |
Local Peer |
US PHYSICAL THERAPY |
NYSE |
1,494.618 |
47.802 |
49.463 |
5.6418 |
0.974 |
Local Peer |
HANGER INC |
NYSE |
814.017 |
29.574 |
19.917 |
25.2006 |
- |
Local Peer |
GLOBAL CORD BLOOD CORPORATION |
NYSE |
542.117 |
8.024 |
10.508 |
- |
- |
Local Peer |
CONCORD MEDICAL SERVICES HLDGS LTD ADS EACH 1 REPR 3 ORD SHS (USD0.0001) |
NYSE |
104.160 |
- |
- |
-2.0532 |
- |
Local Peer |
CAPITAL SENIOR LIVING CORP |
NYSE |
71.488 |
- |
- |
-0.2760 |
- |
Global Peer |
JD HEALTH |
HKEx |
451,543.666 |
- |
- |
-70.6774 |
- |
Global Peer |
PA GOODDOCTOR |
HKEx |
128,611.209 |
- |
- |
6.8510 |
- |
Global Peer |
GUARDANT HEALTH INC |
NASDAQ |
14,976.982 |
- |
- |
13.7126 |
- |
Global Peer |
SONIC HEALTHCARE |
ASX |
15,161.227 |
28.728 |
15.943 |
2.6008 |
2.664 |
Global Peer |
NATERA INC |
NASDAQ |
9,284.830 |
- |
- |
17.3223 |
- |
Global Peer |
AMEDISYS INC |
NASDAQ |
8,628.848 |
68.033 |
- |
- |
- |
Global Peer |
1LIFE HEALTHCARE INC |
NASDAQ |
6,464.432 |
- |
- |
12.0243 |
- |
Global Peer |
LHC GROUP INC |
NASDAQ |
5,942.828 |
62.082 |
57.687 |
3.9761 |
- |
Global Peer |
NEOGENOMICS INC |
NASDAQ |
5,854.545 |
731.272 |
- |
8.7858 |
- |
Global Peer |
JXR |
HKEx |
43,652.197 |
93.981 |
110.595 |
5.2614 |
0.377 |
Other Global Peers |
ACADIA HEALTHCARE (NASDAQ), SMILEDIRECTCLUB INC (NASDAQ), ENSIGN GROUP INC (NASDAQ), OPTION CARE HEALTH INC (NASDAQ), NH HEALTH-B (HKEx), BURNING ROCK BIOTECH LTD SPON ADS EACH REP 1 ORD SHS CL A (NASDAQ), FULGENT GENETICS INC (NASDAQ), GENETRON HOLDINGS LIMITED SPON ADS EACH REP 5 ORD SHS (NASDAQ), HEALIUS LTD (ASX), CASTLE BIOSCIENCES INC (NASDAQ), ADDUS HOMECARE CORP (NASDAQ), PENNANT GROUP INC (NASDAQ), SVH (SET), RAM (SET), TIVITY HEALTH INC (NASDAQ), ONTRAK INC (NASDAQ), KPJ (Bursa), UM HEALTHCARE (HKEx), RADNET INC (NASDAQ), C-MER EYE (HKEx), APRIA INC (NASDAQ), Metro Healthcare Indonesia Tbk. (IDX), OCEANIA HEALTHCARE LTD (ASX), BIODESIX INC (NASDAQ), VIRTUS HEALTH LIMITED (ASX), EUROEYES (HKEx), CARDIFF ONCOLOGY INC (NASDAQ), PROGENITY INC (NASDAQ), GLOBAL X FDS ARTIFICIAL INTELLIGENCE AND TECH ETF (NASDAQ), CRH MEDICAL CORP (NYSE American), AKUMIN INC (NASDAQ), EXAGEN INC (NASDAQ), SANARA MEDTECH INC (NASDAQ), APTINYX INC (NASDAQ), OPTINOSE INC (NASDAQ), ONCOSEC MEDICAL INCORPORATED (NASDAQ), AESTHETIC MEDICAL INT HLDGS GRP LTD SPON ADS EACH REP 3 ORD SHS (NASDAQ), CLOVER CORP (ASX), SILK LASER AUSTRALIA LTD (ASX), BARD1 LIFE SCIENCES LTD (ASX), NOVO INTEGRATED SCIENCES INC (NASDAQ), HEALTHIA LTD (ASX), RAILY AESMED (HKEx), PRO-DEX INC (NASDAQ), OPTIMAX (Bursa), UMP (HKEx), BIOCEPT INC (NASDAQ), ORTHOCELL LIMITED (ASX), Clearbridge (SGX), GUARDION HEALTH SCIENCES INC (NASDAQ), GBS INC (NASDAQ), Cordlife (SGX), Asian Healthcare (SGX), Diagnos Laboratorium Utama Tbk. (IDX), MHCARE (Bursa), KDH (SET), HC Surgical (SGX), HUMAN HEALTH (HKEx), D (SET), Sing Paincare (SGX), CHINA HEALTH (HKEx), TOTAL BRAIN LTD (ASX), Alliance HC (SGX), IMAC HOLDINGS INC (NASDAQ), Medinex (SGX), AsiaMedic (SGX), LIFESPOT HEALTH LTD (ASX), AMERICAN SHARED HOSPITAL SERVICES (NYSE American), SMILE (Bursa), RHT HealthTrust (SGX), REPUBLIC HC (HKEx), MOHO RESOURCES NL (ASX), SMILES INCLUSIVE LTD (ASX), TOPVISN (Bursa) |
Notes:
-
For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is
the average market cap for that industry/index.
-
Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the
industry/index.
-
Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all
companies in the industry/index.
-
Industry/Index Dividend Yield is
calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
-
For Industry/Index calculation, data for foreign currency denominated companies will be converted to the
main market currency using the latest exchange rate.
-
Industry/Index/Peers data is updated daily.
-
Peers are sorted by market capitalisation and only details for the top 10 will be shown.
Total Shareholder Return
Period | Dividend Received | Capital Appreciation | Total Shareholder Return |
---|
Short Term Return |
5 Days |
- | +0.070 | | | +0.07 % |
10 Days |
- | -2.850 | | | -2.71 % |
20 Days |
- | -15.230 | | | -12.98 % |
Medium Term Return |
3 Months |
- | -7.740 | | | -7.04 % |
6 Months |
- | +15.200 | | | +17.48 % |
1 Year |
- | +24.520 | | | +31.59 % |
Long Term Return |
2 Years |
- | +45.090 | | | +79.04 % |
3 Years |
- | +30.230 | | | +42.04 % |
5 Years |
- | +31.630 | | | +44.86 % |
Annualised Return |
Annualised |
- | - | | | +7.69 % |
Notes:
-
Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
-
Script dividends are ignored in this calculation.
Price Movements
1 Year Range |
62.200 - 125.280 |
Change From 1 Year Low |
+39.940 |
% Change From 1 Year Low (%) |
+64.21 |
Change From 1 Year High |
-23.140 |
% Change From 1 Year High (%) |
-18.47 |
2 Years Range |
43.400 - 125.280 |
Change From 2 Years Low |
+58.740 |
% Change From 2 Years Low (%) |
+135.35 |
Change From 2 Years High |
-23.140 |
% Change From 2 Years High (%) |
-18.47 |
5 Years Range |
43.400 - 125.280 |
Change From 5 Years Low |
+58.740 |
% Change From 5 Years Low (%) |
+135.35 |
Change From 5 Years High |
-23.140 |
% Change From 5 Years High (%) |
-18.47 |
Notes:
Price movements are based on adjusted historical data.
Company Background
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
More Information Available
More information is available to our subscribers, including:
- Market Moving News from Dow Jones Newswires
- Consensus Estimates
- Dividend/Distribution History
- Financial Summary with Financial Period Comparison
- Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
- Events Calendar for Results Announcements, Ex-Dates etc
- Insider Buying and Selling Report
If you are an existing subscriber, please login. If not, read up on what
you are missing out in our Help Centre
and join us as a subscriber.
Disclaimer:
While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-
- no liability is accepted for any errors or inaccuracies resulting from your use of these features;
- many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.